
|Videos|September 23, 2021
Dr. Klotz discusses accuracy of miR Sentinel PCC4 Test for prostate cancer
Author(s)Urology Times staff
“We think given the accuracy that this is potentially a game changer,” says Laurence Klotz, MD, FRCSC.
Advertisement
In this video, Laurence Klotz, MD, FRCSC, discusses the miR Sentinel PCC4 Test and how it is advantageous compared to other currently available prostate cancer tests. Klotz is a professor of surgery at the University of Toronto, and the chair of prostate cancer research at the Sunnybrook Health Sciences Centre, Ontario, Canada.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Dosing begins in trial of alpha radioligand therapy for mCRPC
2
Novel tool may help predict early PSA response to ARPIs in mHSPC
3
Fed Ghali, MD, highlights trial of consolidative local therapy following EV/P
4
RCMIGI trial supports feasibility of reduced margins in image-guided prostate radiotherapy
5




















